_6GIxEH.png){kind=logo}
Daikso Co., Ltd.
Founded in 2022, Daikso Co., Ltd. specializes in developing mobile edge AI medical imaging solutions designed for smartphones, tablets, and laptops. The company is committed to advancing fast, accurate, and accessible professional medical screening—anytime, anywhere.
Daikso’s proprietary lightweight AI architecture earned first place in the international MICCAI medical image analysis competition and has been recognized by academic and industry leaders across multiple countries.
The company’s core technology centers on an ultra-lightweight AI engine, which is modular and flexibly integrable into various portable ultrasound probes. This enables the transformation of conventional devices into intelligent screening tools, suitable for primary clinics, home care, long-term care, ambulances, and remote areas—effectively overcoming the cost and labor barriers associated with large-scale medical equipment.
Daikso’s interdisciplinary team brings together expertise in AI, edge computing, medical device regulations, and clinical practice. The company actively collaborates with industry leaders such as GE Healthcare, BenQ Qisda, APEX Medical, and Pentium Intelligence Biotech, and maintains strong partnerships with Chang Gung Medical System, the NVIDIA Startup Inception Program, and Imedi Co., Ltd. In 2025, Daikso was named a Top 10 Startup at Computex InnoVEX, demonstrating its global potential and competitiveness.
In 2024, Daikso successfully obtained three TFDA certifications, including a standard medical device manufacturing license. By 2025, it aims to expand to nine TFDA-certified products and begin FDA, NMPA, and Southeast Asian regulatory approvals. Looking ahead to 2026, Daikso plans to scale globally and set a new standard for accessible AI-powered medical screening